Rambam Health Care Campus, Israel

​

Pharmachal and tier-1 Israeli trauma hospital Rambam are co-developing a new product for treating burns, wounds, haemophilia, and diabetic ulcers.

 

The collaboration will combine Pharmachal’s patented mini-emulsion “NDDS” drug delivery technology with a novel peptide drug developed  at Rambam that has shown significant potential to speed up wound healing, coagulate bleeding, and encourage the formation of new blood vessels.

​

www.rambam.org.il/en/